Chronic graft-versus-host disease (cGVHD) affects 30-50% of hematopoietic stem cell transplant (HSCT) patients with skin involvement in about 70%. Among sclerodermiform manifestations, fasciitis, similar in many aspects to eosinophilic fasciitis, has rarely been reported as the only clinical sign of cGVHD. 1, 2 This form of fasciitis is unusual for several reasons: late onset (mean 841 days compared with 322 days for other cGVHD scleroses), beginning with edema rather than lichenoid papules, as is characteristic of other cutaneous manifestations, and failure to respond to steroids and other conventional treatment for cGVHD. 2 Moreover, it differs in two aspects from all other forms of sclerodermiform cGVHD: (i) involvement of the muscle fascia, often without the dermal and epidermal involvement present in all other forms, and (ii) exclusively acral localisation.
A 54-year-old woman underwent allogeneic blood HSCT from an HLA-identical sibling for first relapse of diffuse large B-cell non-Hodgkin lymphoma. Her course was complicated by acute GVHD followed by progressive cGVHD with dry mouth and eyes, but no skin involvement. Conventional immunosuppressive therapy led to complete recovery in 6 months. At 15 months after transplant, the patient complained of painful progressive edema of the upper and lower limbs. Prednisone and cyclosporine failed to bring about any clinical improvement. The patient was referred to us. Physical examination of the chest and heart were normal, but the liver was enlarged. No lymphadenopathy was found. The patient complained of painful upper limbs and could not raise them above her head or completely extend the elbows ( Figure 1a ). Passive mobilization showed stiffness of the joints with reduced extension of the elbow and shoulder joints, especially the left shoulder. Dermatological examination showed moderate edema of the arms. On palpation, the skin appeared taut due to the edema and adhered slightly to the underlying layers. Blood tests showed slight iron deficiency anemia and elevated liver function indices, ESR (26 mm/h) and eosinophils (8.1%). ANA was positive (1:160 with nucleolar pattern), and ENA negative. Electromyography indicated myopathy of the left deltoid muscle, while all other muscles were normal. Sensorimotor neurographic parameters were all within normal limits. X-ray of the left elbow did not show any structural alterations of the bones. Ultrasonography of the left elbow showed slight hyperechogenicity and lack of echostructural omogeneity of the forearm extensor and flexor muscles. Histological examination of a full-thickness biopsy specimen from the left forearm showed that thickening of interlobular septa was observed in subcutaneous fat. The fascia was thickened with angiocentric infiltration consisting largely of lymphocytes with eosinophilic granulocytes (Figure 2) . A diagnosis of fasciitis associated with cGVHD was made.
The patient was treated with two consecutive sessions of extracorporeal photochemotherapy (ECP) every 2 weeks, while immunosuppressive therapy was continued. ECP was performed by UVAR s apparatus (Therakos, Westchester, PA, USA). At follow-up examination 3 months after the start of ECP (10th cycle), there was clear improvement of symptoms, with reduction of edema and improved movement of both elbows. The right shoulder was less stiff, but the left shoulder had not improved. At a subsequent followup at about 6 months (22nd cycle of ECP), movement of both the elbows had further improved: right elbow from 1251 to 1451 (Figure 1b ) and left elbow from 1081 to 1141. ECP enabled the dose of immunosuppressives to be reduced (cyclosporine 2.5 mg/kg/day and prednisone 20 mg/day). Blood tests after ECP treatment showed improvement in liver function indices, ESR (18 mm/h) and eosinophils (3.4%).
Fasciitis is a rare manifestation of cGVHD. 1 The second reported case was classified as eosinophilic fasciitis. 2 More Figure 1 Right upper limb before (a) and after (b) ECP treatment.
recently, Janin et al 3 did a retrospective cohort study of 14 cases and proposed classifying it as a separate entity among the sclerodermiform manifestations of cGVHD, distinguishing it from classical eosinophilic fasciitis on the basis of certain minor clinical aspects, but mainly its poor response to conventional treatment. Fasciitis after HSCT seems to evolve more rapidly (2-3 months) and to cause worse sclerotic changes than those observed in eosinophilic fasciitis. A major characteristic of cGVHD fasciitis is its failure to respond to steroid therapy and other conventional treatments for cGVHD, either in the initial stage of inflammatory edema or in the later sclerotic stage. Contractures and joint stiffness usually occur in late stages of the disease. These orthopedic complications impair the quality of life and require long-term conservative management with physical therapy and orthotics. Surgical release of joint contractures does not seem to improve functional quality, making affected joints unresponsive to further conservative treatment. 4 To the best of our knowledge, this is the first case of cGVHD fasciitis treated with ECP. ECP is currently a consolidated treatment for visceral and cutaneous involvement in chronic GVHD, [5] [6] [7] [8] [9] [10] [11] [12] and has also proven effective in cases of eosinophilic fasciitis, 10 a disease similar to cGVHD fasciitis. Although we have treated only one case, the results are encouraging. 
